People · Operator
Named in public records as an officer, director or promoter · active 2017–2022 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Beam Therapeutics Inc. | — | Pharmaceuticals | Series D+ | $218.6M | $4.8B | 2018 |
| TDH Holdings, Inc. | — | Other | Series A | $6.4M | $49.1M | 2022 |
| H3D, Inc. | — | Other | Seed | $2.8M | $52.0M | 2017 |
Feng Zhang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Feng Zhang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Kristina Burow | 1 | 16 |
| Robert Nelson | 1 | 7 |
| STEPHEN KNIGHT | 1 | 6 |
| Michael Yi | 1 | 4 |
| John Evans | 1 | 4 |
| John Yu | 1 | 3 |
| Mark Fishman | 1 | 3 |
| Zhong He | 1 | 2 |
| Caifen Zou | 1 | 1 |
| Qiu Li | 1 | 1 |
| Owens Meng | 1 | 1 |
| Dandan Liu | 1 | 1 |
| CAROLE HO | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.